Alternatives to Infiniplex

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

A medical platform connecting patients and physicians with genetic expertise.

Transforming healthcare by turning scientific fiction into scientific facts.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Develops a computational model of the human body for drug discovery and development.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

AI-powered spatial biology platform for precision medicine and drug development.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

AI-powered personalized screening for early disease detection using non-invasive methods.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Personalized diagnostics for cancer genomic markers at the point of treatment.

AI-powered platform personalizing and optimizing cancer patient monitoring and treatment.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

AI-powered platform to enhance fertility treatment success rates and patient experience.

A platform for functional, integrative, and longevity medicine.

AI-powered system for real-time sperm cell analysis and selection for fertility treatments.

Digital pathology imaging technology and AI-driven precision pathology software.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Igentify is a digital health company providing a Digital Genetic Assistant platform for clinicians, laboratories, and patients.

AI-driven platform for faster and more efficient diagnosis of women's health issues.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

AI-powered platform for early detection and treatment selection of autoimmune diseases.

Platform for managing high-risk populations prone to severe illnesses, enabling early diagnosis and cost reduction.

Liger Medical develops breakthrough optical diagnostic devices and software for early cancer detection and other medical purposes.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-powered early cancer detection using proprietary image and pattern recognition technology.

Microbiome technology platform for developing novel therapeutics.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

Deep learning-powered pathology analysis for personalized cancer management and treatment.

A molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer.

AI-driven platform for protein-level disease mapping and drug discovery.

AI-powered blood test for early cancer detection and subtyping.

AI-powered epiproteomic analysis platform for mass spectrometry data.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

High-resolution T-cell receptor repertoire analysis for immunological insights and therapeutic development.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Changing the trajectory of human health, one baby at a time.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.